• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Words of Wisdom: Re: A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Obstruction.

作者信息

Michel Martin C

出版信息

Eur Urol. 2016 Jan;69(1):174. doi: 10.1016/j.eururo.2015.10.032.

DOI:10.1016/j.eururo.2015.10.032
PMID:27096149
Abstract
摘要

相似文献

1
Words of Wisdom: Re: A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Obstruction.智慧之言：关于坦索罗辛单药治疗及其与米拉贝隆联合治疗良性前列腺梗阻所致膀胱过度活动症疗效的随机对照研究
Eur Urol. 2016 Jan;69(1):174. doi: 10.1016/j.eururo.2015.10.032.
2
A randomized controlled study of the efficacy of tamsulosin monotherapy and its combination with mirabegron for overactive bladder induced by benign prostatic obstruction.坦索罗辛单药治疗及其与米拉贝隆联合治疗良性前列腺梗阻所致膀胱过度活动症疗效的随机对照研究。
J Urol. 2015 Mar;193(3):921-6. doi: 10.1016/j.juro.2014.09.091. Epub 2014 Sep 22.
3
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.托特罗定与坦索罗辛治疗男性下尿路症状合并膀胱过度活动症：一项随机对照试验。
JAMA. 2006 Nov 15;296(19):2319-28. doi: 10.1001/jama.296.19.2319.
4
Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study).坦索罗辛、度他雄胺和咪达非那新联合治疗良性前列腺增生相关膀胱过度活动症症状的疗效和安全性：一项多中心、随机、开放标签、对照试验（直接研究）
Int J Urol. 2017 Jul;24(7):525-531. doi: 10.1111/iju.13359. Epub 2017 May 2.
5
Re: A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Obstruction: K. Ichihara, N. Masumori, F. Fukuta, T. Tsukamoto, A. Iwasawa and Y. Tanaka J Urol 2015; 193: 921-926.回复：坦索罗辛单药治疗及其与米拉贝隆联合治疗良性前列腺梗阻所致膀胱过度活动症疗效的随机对照研究：K. 石原、N. 增森、F. 深田、T. 冢本、A. 岩泽和Y. 田中 《泌尿外科杂志》2015年；193卷：921 - 926页
J Urol. 2015 Aug;194(2):598-9. doi: 10.1016/j.juro.2015.02.2946. Epub 2015 May 7.
6
[Efficacy of combination therapy of tamsulosin and solifenacin for mild and moderate benign prostatic hyperplasia with overactive bladder].坦索罗辛与索利那新联合治疗轻中度良性前列腺增生合并膀胱过度活动症的疗效
Zhonghua Nan Ke Xue. 2014 Mar;20(3):239-43.
7
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.在患有下尿路症状和膀胱过度活动症的男性中，使用或不使用坦索罗辛的缓释托特罗定：对通过国际前列腺症状评分评估的泌尿症状的影响。
BJU Int. 2008 Nov;102(9):1133-9. doi: 10.1111/j.1464-410X.2008.07761.x. Epub 2008 May 26.
8
Combination of solifenacin with tamsulosin reduces prostate volume and vascularity as opposed to tamsulosin monotherapy in patients with benign prostate enlargement and overactive bladder symptoms: Results from a randomized pilot study.与坦索罗辛单药治疗相比，索利那新与坦索罗辛联合使用可减少良性前列腺增生和膀胱过度活动症患者的前列腺体积和血管形成：一项随机试点研究的结果。
Int J Urol. 2018 Aug;25(8):737-745. doi: 10.1111/iju.13721. Epub 2018 Jul 15.
9
Cognitive functions and health-related quality of life in men with benign prostatic hyperplasia and symptoms of overactive bladder when treated with a combination of tamsulosin and solifenacin in a higher dosage.坦索罗辛与索利那新高剂量联合治疗良性前列腺增生伴膀胱过度活动症男性患者的认知功能及健康相关生活质量
Aging Male. 2018 Jun;21(2):121-129. doi: 10.1080/13685538.2017.1398723. Epub 2017 Nov 7.
10
Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy.在坦索罗辛单药治疗后患有良性前列腺梗阻和膀胱过度活动症残留症状的男性中持续使用索利那新附加疗法。
Int J Clin Pract. 2014 Dec;68(12):1496-502. doi: 10.1111/ijcp.12483. Epub 2014 Oct 6.

引用本文的文献

1
The efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy: A systematic review and meta-analysis.米拉贝隆对接受坦索罗辛治疗的男性良性前列腺增生所致膀胱过度活动症的疗效和安全性：一项系统评价和荟萃分析。
Medicine (Baltimore). 2020 Jan;99(4):e18802. doi: 10.1097/MD.0000000000018802.
2
Effect of α-receptor blockers on lower urinary tract symptoms, sexual function and quality of life in young and middle-aged men with benign prostatic hyperplasia.α受体阻滞剂对中青年良性前列腺增生男性下尿路症状、性功能及生活质量的影响。
Exp Ther Med. 2017 Jul;14(1):587-592. doi: 10.3892/etm.2017.4518. Epub 2017 May 29.